πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 812 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7595191

Isolation and purification of P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7572449

Vaccine against Yersinia comprising one or two antibodies, one specific for Yersinia pesti

The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and Northern Ireland Β· Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7572891

Kidney-specific tumor vaccine directed against kidney tumor antigen G-250

The Regents of the University of California Β· Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7563883

Recombinant P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7553490

Vaccines against Escherichia coli O157 infection

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7541043

Vaccine for protection against Shigella sonnei disease

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7538183

HPV vaccine comprising peptides from host cell proteins

University College Cardiff Consultants Limited Β· Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7527802

Vaccine for transcutaneous immunization

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7527797

Vibrio cholerae 0139 conjugate vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7517531

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3β€²-UTR of den

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7514529

Peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccin

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7485440

Production of attenuated respiratory syncytial virus vaccines involving modification of M2

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7485415

Sequence analysis of the tetravalent rotavirus vaccine

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7479550

Amyloid Ξ² gene vaccines

The Board of Regents of the University of Texas System Β· Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7431929

Use of vaccinia virus deleted for the E3L gene as a vaccine vector

THE ARIZONA BOARD OF REGENTS Β· Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7422755

Antimultiorganism glycoconjugate vaccine

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7417136

Nucleic acid vaccines for prevention of flavivirus infection

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION Β· Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7413864

Treating cancer using a telomerase vaccine

The Regents of the University of Colorado Β· Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7407935

Ricin toxin A-chain fragment for use as a vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7407664

Peptide vaccines against group A streptococci

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7407658

Vaccines for blocking transmission of plasmodium vivax

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7388089

Anti-arthropod vector vaccines method of selecting and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7378257

Bacterial superantigen vaccines

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7374931

Vaccine against staphylococcus intoxication

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted